ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD

GlaxoSmithKline · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
chronic-obstructivepulmonary-disease
pulmonary disease, chronic obstructive, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 843202
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.